Nan Dai
- Cancer Research top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 12
- DNA Repair Mechanisms 11
- Advanced biosensing and bioanalysis techniques 7
-
- Lung Cancer Research Studies 7
- Cancer Immunotherapy and Biomarkers 6
-
- Gastric Cancer Management and Outcomes 9
-
- Gastrointestinal Tumor Research and Treatment 7
-
- Gastrointestinal disorders and treatments 6
- Co-authors
- Mengxia LiZhaoyang ZhongDong WangYi QingShiheng ZhangJinlu ShanChengyuan QianDebing Xiang
- Journals
- Nucleic Acids Research (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Nan Dai
70 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 258
- Molecular Biology 760
- Oncology 227
- Pulmonary and Respiratory Medicine 166
- Electrochemistry 30
Countries citing papers authored by Nan Dai
This map shows the geographic impact of Nan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Dai more than expected).
Fields of papers citing papers by Nan Dai
This network shows the impact of papers produced by Nan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Dai. The network helps show where Nan Dai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nan Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 6 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 16 | |
| 10 | 2018 | 54 | |
| 11 | 2018 | 29 | |
| 12 | 2016 | 2 | |
| 13 | 2014 | 7 | |
| 14 | 2014 | 6 | |
| 15 | 2014 | 26 | |
| 16 | 2013 | 9 | |
| 17 | 2013 | 6 | |
| 18 | 2009 | 26 | |
| 19 | 2008 | 64 | |
| 20 | Research and Implementation of ID3 Based on Distributed Database System | 2005 | 1 |
About Nan Dai
Nan Dai is a scholar working on Gastroenterology, Oncology and Cancer Research, having authored 75 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), DNA Repair Mechanisms (11 papers), Gastric Cancer Management and Outcomes (9 papers), Gastrointestinal Tumor Research and Treatment (7 papers), Lung Cancer Research Studies (7 papers), Advanced biosensing and bioanalysis techniques (7 papers), Gastrointestinal disorders and treatments (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (258 citations), Molecular Biology (760 citations) and Oncology (227 citations). Nan Dai has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Mengxia Li, Zhaoyang Zhong, Dong Wang, Yi Qing, Shiheng Zhang, Jinlu Shan, Chengyuan Qian, Debing Xiang, Yanping Cun and Cheng‐Xiong Xu. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.